nach oben

Current HIV/AIDS Reports

Erschienen in:

18.06.2020 | Behavioral-Bio-Medical Interface (RJ DiClemente and JL Brown, Section Editors)

ART Adherence Among Men Who Have Sex with Men Living with HIV: Key Challenges and Opportunities

verfasst von: Katherine G. Quinn, Dexter R. Voisin

Erschienen in: Current HIV/AIDS Reports | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

In the USA, gay, bisexual, and other men who have sex with men (MSM) are disproportionately affected by HIV. High levels of adherence to antiretroviral therapy (ART) can dramatically improve outcomes for persons living with HIV and reduce the risk of HIV transmission to others. Yet, there are numerous individual, social, and structural barriers to optimal ART adherence. Many of these factors disproportionately impact Black MSM and may contribute to their poorer rates of ART adherence. This review synthesizes the key challenges and intervention opportunities to improve ART adherence among MSM in the USA.

Recent Findings

Key challenges to ART adherence include stigma, violence, depression, and substance use. Black MSM are significantly disadvantaged by several of these factors. There are several promising interventions to improve ART adherence among MSM, and there remains an opportunity to culturally tailor these to the needs of Black MSM populations to enhance adherence.

Summary

Despite high rates of HIV among MSM, there continues to be a paucity of research on the various contributors to poor ART adherence among this population. Similarly, few interventions have been tested that lead to increased and sustained ART adherence among Black MSM.

Centers for Disease Control and Prevention. HIV Surveillance Report, 2018. Vol 30.; 2019. https://doi.org/10.1017/CBO9781107415324.004

Hess K, Hu X, Lansky A, Mermin J, Hall HI. Lifetime risk of a diagnosis of HIV infection in the United States. Ann Epidemiol. 2017;27(4):238–43.CrossRef

White House Office of National AIDS Policy. National HIV/AIDS Strategy for the United States: Updated to 2020. Washington, DC: The White House; 2015. https://www.aids.gov/federal-resources/national-hiv-aids-strategy/nhas-update.pdf.

Hogg RS. Understanding the HIV care continuum. Lancet HIV. 2018;5(6):e269–70. https://doi.org/10.1016/S2352-3018(18)30102-4.CrossRefPubMed

Kay ES, Batey DS, Mugavero MJ. The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future. AIDS Res Ther. 2016;13(1). https://doi.org/10.1186/s12981-016-0120-0.

Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.CrossRef

Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA - J Am Med Assoc. 2010;304:321–33. https://doi.org/10.1001/jama.2010.1004.CrossRef

US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. October. 2012. https://doi.org/10.3390/v7102887

Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382:1525–33. https://doi.org/10.1016/S0140-6736(13)61809-7.CrossRefPubMedPubMedCentral

10.

Chaiyachati KH, Ogbuoji O, Price M, Suthar AB, Negussie EK, Bärnighausen T. Interventions to improve adherence to antiretroviral therapy: a rapid systematic review. AIDS. 2014;28:S187–204. https://doi.org/10.1097/QAD.0000000000000252.CrossRefPubMed

11.

Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang LW, Gross R, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med. 2012;156(11):817–33.CrossRef

12.

Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to antiretroviral therapy and virologic failure. Med (United States). 2016. https://doi.org/10.1097/MD.0000000000003361.

13.

WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach; 2013. ISBN 978 92 4 150572 7.

14.

Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.CrossRef

15.

Lima VD, Harrigan R, Bangsberg DR, et al. The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr. 2009;50(5):529–36. https://doi.org/10.1097/QAI.0b013e31819675e9.CrossRefPubMedPubMedCentral

16.

Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. Aids. 2002;16(7):1051–8.CrossRef

17.

Wood E, Hogg RS, Yip B, Harrigan PR, O’Shaughnessy MV, Montaner JSG. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4 cell count is 0.200 to 0.350× 109 cells/L. Ann Intern Med. 2003;139(10):810–6.CrossRef

18.

Benator DA, Elmi A, Rodriguez MD, Gale HB, Kan VL, Hoffman HJ, et al. True durability: HIV virologic suppression in an urban clinic and implications for timing of intensive adherence efforts and viral load monitoring. AIDS Behav. 2015;19(4):594–600.CrossRef

19.

Eaton EF, Saag MS, Mugavero M. Engagement in human immunodeficiency virus care: linkage, retention, and antiretroviral therapy adherence. Infect Dis Clin N Am. 2014;28(3):355–69.CrossRef

20.

Burman WJ, Grund B, Roediger MP, et al. The impact of episodic CD4 cell count-guided antiretroviral therapy on quality of life. J Acquir Immune Defic Syndr. 2008;47(2):185–93. https://doi.org/10.1097/QAI.0b013e31815acaa4.CrossRefPubMed

21.

Levi J, Raymond A, Pozniak A, Vernazza P, Kohler P, Hill A. Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades. BMJ Glob Health. 2016;1:e000010. https://doi.org/10.1136/bmjgh-2015-000010.CrossRefPubMedPubMedCentral

22.

Linley L, Johnson AS, Song R, et al. Estimated HIV incidence and prevalence in the United States, 2010–2016. HIV Surveill Suppl Rep. 2019.

23.

Zanoni BC, Mayer KH. The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities. AIDS Patient Care STDs. 2014;28(3):128–35.CrossRef

24.

Buchacz K, Armon C, Tedaldi E, Palella FJ Jr, Novak RM, Ward D, et al. Disparities in HIV viral load suppression by race/ethnicity among men who have sex with men in the HIV outpatient study. AIDS Res Hum Retrovir. 2018;34:357–64. https://doi.org/10.1089/aid.2017.0162.CrossRef

25.

Beer L, Bradley H, Mattson CL, Johnson CH, Hoots B, Shouse RL. Trends in racial and ethnic disparities in antiretroviral therapy prescription and viral suppression in the United States, 2009–2013. J Acquir Immune Defic Syndr. 2016. https://doi.org/10.1097/QAI.0000000000001125.

26.

Crepaz N, Dong X, Wang X, Hernandez AL, Irene HH. Racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons receiving HIV care - United States, 2014. Morb Mortal Wkly Rep. 2018. https://doi.org/10.15585/mmwr.mm6704a2.

27.

Simoni JM, Huh D, Wilson IB, et al. Racial/ethnic disparities in ART adherence in the United States: findings from the MACH14 study. J Acquir Immune Defic Syndr. 2012;60(5):466–72. https://doi.org/10.1097/QAI.0b013e31825db0bd.CrossRefPubMedPubMedCentral

28.

Dailey AF, Johnson AS, Wu B. HIV care outcomes among blacks with diagnosed HIV — United States, 2014. Morb Mortal Wkly Rep. 2017. https://doi.org/10.15585/mmwr.mm6604a2.

29.

MacDonell K, Naar-King S, Huszti H, Belzer M. Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV. AIDS Behav. 2013;17(1):86–93.CrossRef

30.

Sweeney SM, Vanable PA. The association of HIV-related stigma to HIV medication adherence: a systematic review and synthesis of the literature. AIDS Behav. 2016;20(1):29–50. https://doi.org/10.1007/s10461-015-1164-1.CrossRefPubMed

31.

Quinn KG, Reed SJ, Dickson-Gomez J, Kelly JA. An exploration of syndemic factors that influence engagement in HIV care among Black men. Qual Health Res. 2018;28(7). https://doi.org/10.1177/1049732318759529.

32.

Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13(6):1160–77.CrossRef

33.

Nyblade LC. Measuring HIV stigma: existing knowledge and gaps. Psychol Health Med. 2006;11(3):335–45.CrossRef

34.

Link BG. Understanding labeling effects in the area of mental disorders: an assessment of the effects of expectations of rejection. Am Sociol Rev. 1987;52:96. https://doi.org/10.2307/2095395.CrossRef

35.

Quinn K, Bowleg L, Dickson-Gomez J. “The fear of being Black plus the fear of being gay”: the effects of intersectional stigma on PrEP use among young Black gay, bisexual, and other men who have sex with men. Soc Sci Med. 2019;Jul(232):86–93. https://doi.org/10.1016/j.socscimed.2019.04.042.CrossRef

36.

Sue DW. Microaggressions in everyday life: race, gender, and sexual orientation: Wiley; Hoboken, NJ; 2010.

37.

Rao D, Feldman BJ, Fredericksen RJ, Crane PK, Simoni JM, Kitahata MM, et al. A structural equation model of HIV-related stigma, depressive symptoms, and medication adherence. AIDS Behav. 2012;16(3):711–6.CrossRef

38.

Sayles JN, Wong MD, Kinsler JJ, Martins D, Cunningham WE. The association of stigma with self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS. J Gen Intern Med. 2009;24(10):1101–8.CrossRef

39.

Li L, Lee SJ, Wen Y, Lin C, Wan D, Jiraphongsa C. Antiretroviral therapy adherence among patients living with HIV/AIDS in Thailand. Nurs Health Sci. 2010;12:212–20. https://doi.org/10.1111/j.1442-2018.2010.00521.x.CrossRefPubMedPubMedCentral

40.

Bird ST, Bogart LM, Delahanty DL. Health-related correlates of perceived discrimination in HIV care. AIDS Patient Care STDs. 2004;18:19–26. https://doi.org/10.1089/108729104322740884.CrossRefPubMed

41.

Galvan FH, Bogart LM, Klein DJ, Wagner GJ, Chen YT. Medical mistrust as a key mediator in the association between perceived discrimination and adherence to antiretroviral therapy among HIV-positive Latino men. J Behav Med. 2017;40:784–93. https://doi.org/10.1007/s10865-017-9843-1.CrossRefPubMedPubMedCentral

42.

Quinn KG, Dickson-Gomez J, Zarwell M, Pearson B, Lewis M. “A gay man and a doctor are just like, a recipe for destruction”: how racism and homonegativity in healthcare settings influence PrEP uptake among young Black MSM. AIDS Behav. 2019;23(7):1951–63. https://doi.org/10.1007/s10461-018-2375-z.CrossRefPubMedPubMedCentral

43.

Eaton LA, Driffin DD, Kegler C, Smith H, Conway-Washington C, White D, et al. The role of stigma and medical mistrust in the routine health care engagement of black men who have sex with men. Am J Public Health. 2015;105(2):e75–82.CrossRef

44.

Turan B, Rogers AJ, Rice WS, Atkins GC, Cohen MH, Wilson TE, et al. Association between perceived discrimination in healthcare settings and HIV medication adherence: mediating psychosocial mechanisms. AIDS Behav. 2017;21:3431–9. https://doi.org/10.1007/s10461-017-1957-5.CrossRefPubMedPubMedCentral

45.

Washington HA. Medical apartheid: the dark history of medical experimentation on Black Americans from colonial times to the present: Doubleday Books; Hamburg, Germany; 2006.

46.

Quinn, KG, Kelly, JA, DiFranceisco, WJ, Tamira, SS, Petroll, AE, Sanders, C, St. Lawrence, JS, Amirkhanian, YA. The health and sociocultural correlates or AIDS genocidal beliefs and medical mistrust among African American MSM. AIDS and Behavior. 2018. 22(6):1814–1825.

47.

Bogart LM, Thorburn S. Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans? JAIDS J Acquir Immune Defic Syndr. 2005;38(2):213–8.CrossRef

48.

Armstrong K, McMurphy S, Dean LT, Micco E, Putt M, Halbert CH, et al. Differences in the patterns of health care system distrust between blacks and whites. J Gen Intern Med. 2008;23:827–33. https://doi.org/10.1007/s11606-008-0561-9.CrossRefPubMedPubMedCentral

49.

Earnshaw VA, Bogart LM, Dovidio JF, Williams DR. Stigma and racial/ethnic HIV disparities: moving toward resilience. Am Psychol. 2013;68(4):225–36.CrossRef

50.

Bogart LM, Wagner GJ, Galvan FH, Klein DJ. Longitudinal relationships between antiretroviral treatment adherence and discrimination due to HIV-serostatus, race, and sexual orientation among African–American men with HIV. Ann Behav Med. 2010;40(2):184–90.CrossRef

51.

Dale SK, Bogart LM, Wagner GJ, Galvan FH, Klein DJ. Medical mistrust is related to lower longitudinal medication adherence among African-American males with HIV. J Health Psychol. 2016;21(7):1311–21.CrossRef

52.

Mutchler MG, Bogart LM, Klein DJ, Wagner GJ, Klinger IA, Tyagi K, et al. Age matters: differences in correlates of self-reported HIV antiretroviral treatment adherence between older and younger black men who have sex with men living with HIV. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2019;31:965–72. https://doi.org/10.1080/09540121.2019.1612020.CrossRef

53.

Earnshaw VA, Smith LR, Chaudoir SR, Amico KR, Copenhaver MM. HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework. AIDS Behav. 2013;17(5):1785–95.CrossRef

54.

Nachega JB, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, et al. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses. 2004;20:1053–6. https://doi.org/10.1089/aid.2004.20.1053.CrossRefPubMed

55.

Watt MH, Maman S, Golin CE, Earp JA, Eng E, Bangdiwala SI, et al. Factors associated with self-reported adherence to antiretroviral therapy in a Tanzanian setting. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2010;22:381–9. https://doi.org/10.1080/09540120903193708.CrossRef

56.

Okoror TA, Falade CO, Olorunlana A, Walker EM, Okareh OT. Exploring the cultural context of HIV stigma on antiretroviral therapy adherence among people living with HIV/AIDS in Southwest Nigeria. AIDS Patient Care STDs. 2013;27:55–64. https://doi.org/10.1089/apc.2012.0150.CrossRefPubMed

57.

Camacho G, Kalichman S, Katner H. Anticipated HIV-related stigma and HIV treatment adherence: the indirect effect of medication concerns. AIDS Behav. 2019;24:185–91. https://doi.org/10.1007/s10461-019-02644-z.CrossRef

58.

Quinn K, Voisin DRDRDR, Bouris A, et al. Multiple dimensions of stigma and health related factors among young black men who have sex with men. AIDS Behav. 2017;21(1):207–16. https://doi.org/10.1007/s10461-016-1439-1.CrossRefPubMedPubMedCentral

59.

Blake Helms C, Turan JM, Atkins G, Kempf MC, Clay OJ, Raper JL, et al. Interpersonal mechanisms contributing to the association between HIV-related internalized stigma and medication adherence. AIDS Behav. 2017;21(1):238–47. https://doi.org/10.1007/s10461-016-1320-2.CrossRefPubMed

60.

• Turan B, Hatcher AM, Weiser SD, Johnson MO, Rice WS, Turan JM. Framing mechanisms linking HIV-related stigma, adherence to treatment, and health outcomes. Am J Public Health. 2017;107(6):863–9 The authors develop a conceptual framework to highlight how various dimensions of stigma, including structural- and individual-levels of stigma, affect the health of individuals living with HIV. CrossRef

61.

Seghatol-Eslami VC, Dark HE, Raper JL, Mugavero MJ, Turan JM, Turan B. Brief report: interpersonal and intrapersonal factors as parallel independent mediators in the association between internalized HIV stigma and ART adherence. J Acquir Immune Defic Syndr. 2017;74:e18–22. https://doi.org/10.1097/QAI.0000000000001177.CrossRefPubMedPubMedCentral

62.

Earnshaw VA, Bogart LM, Laurenceau JP, Chan BT, Maughan-Brown BG, Dietrich JJ, et al. Internalized HIV stigma, ART initiation and HIV-1 RNA suppression in South Africa: exploring avoidant coping as a longitudinal mediator. J Int AIDS Soc. 2018;21:e25198. https://doi.org/10.1002/jia2.25198.CrossRefPubMedPubMedCentral

63.

Stangl AL, Earnshaw VA, Logie CH, van Brakel W, C. Simbayi L, Barré I, et al. The health stigma and discrimination framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. BMC Med. 2019;17:31. https://doi.org/10.1186/s12916-019-1271-3.CrossRefPubMedPubMedCentral

64.

Quinn K, Dickson-Gomez J, Broaddus M, Kelly JA. “It’s almost like a crab-in-a-barrel situation”: stigma, social support, and engagement in care among black men living with HIV. AIDS Educ Prev. 2018;30(2). https://doi.org/10.1521/aeap.2018.30.2.120.

65.

Kamen C, Flores S, Taniguchi S, Khaylis A, Lee S, Koopman C, et al. Sexual minority status and trauma symptom severity in men living with HIV/AIDS. J Behav Med. 2012;35:38–46. https://doi.org/10.1007/s10865-011-9329-5.CrossRefPubMed

66.

Klot JF, Auerbach JD, Berry MR. Sexual violence and HIV transmission: summary proceedings of a scientific research planning meeting. Am J Reprod Immunol. 2013. https://doi.org/10.1111/aji.12033.

67.

Schnurr PP, Green BL. Understanding relationships among trauma, posttraumatic stress disorders, and health outcomes. Adv Mind Body Med. 2004. https://doi.org/10.1037/10723-010.

68.

Quinn K, Voisin DR, Bouris A, Schneider J. Psychological distress, drug use, sexual risks and medication adherence among young HIV-positive Black men who have sex with men: exposure to community violence matters. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2016;28(7). https://doi.org/10.1080/09540121.2016.1153596.

69.

Brown MJ, Harrison SE, Li X. Gender disparities in traumatic life experiences and antiretroviral therapy adherence among people living with HIV in South Carolina. AIDS Behav. 2019;23:2904–15. https://doi.org/10.1007/s10461-019-02440-9.CrossRefPubMed

70.

Hotton AL, Keene L, Corbin DE, Schneider J, Voisin DR. The relationship between Black and gay community involvement and HIV-related risk behaviors among black men who have sex with men. J Gay Lesbian Soc Serv. 2018;30:64–81. https://doi.org/10.1080/10538720.2017.1408518.CrossRefPubMed

71.

Anderson JC, Campbell JC, Glass NE, Decker MR, Perrin N, Farley J. Impact of intimate partner violence on clinic attendance, viral suppression and CD4 cell count of women living with HIV in an urban clinic setting. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2018;30:399–408. https://doi.org/10.1080/09540121.2018.1428725.CrossRef

72.

Onono M, Odwar T, Abuogi L, Owuor K, Helova A, Bukusi E, et al. Effects of depression, stigma and intimate partner violence on postpartum women’s adherence and engagement in HIV care in Kenya. AIDS Behav. 2019;24:1807–15. https://doi.org/10.1007/s10461-019-02750-y.CrossRef

73.

Finneran C, Stephenson R. Intimate partner violence among men who have sex with men: a systematic review. Trauma Violence Abuse. 2013. https://doi.org/10.1177/1524838012470034.

74.

Stephenson R, Khosropour C, Sullivan P. Reporting of Intimate Partner Violence among Men Who Have Sex with Men in an Online Survey. West J Emerg Med. 2010;11(3):242–246.

75.

Craft SM, Serovich JM. Family-of-origin factors and partner violence in the intimate relationships of gay men who are HIV positive. J Interpers Violence. 2005;20:777–91. https://doi.org/10.1177/0886260505277101.CrossRefPubMedPubMedCentral

76.

Paul JP, Catania J, Pollack L, Stall R. Understanding childhood sexual abuse as a predictor of sexual risk-taking among men who have sex with men: The Urban Men’s Health Study. Child Abuse Negl. 2001;25:557–84. https://doi.org/10.1016/S0145-2134(01)00226-5.CrossRefPubMed

77.

Welles SL, Baker AC, Miner MH, Brennan DJ, Jacoby S, Rosser BRS. History of childhood sexual abuse and unsafe anal intercourse in a 6-city study of HIV-positive men who have sex with men. Am J Public Health. 2009;99:1079–86. https://doi.org/10.2105/AJPH.2007.133280.CrossRefPubMedPubMedCentral

78.

Soto T, Komaie G, Neilands TB, Johnson MO. Exposure to crime and trauma among HIV-infected men who have sex with men: associations with HIV stigma and treatment engagement. J Assoc Nurses AIDS Care. 2013;24:299–307. https://doi.org/10.1016/j.jana.2012.11.008.CrossRefPubMed

79.

Yiaslas TA, Kamen C, Arteaga A, Lee S, Briscoe-Smith A, Koopman C, et al. The relationship between sexual trauma, peritraumatic dissociation, posttraumatic stress disorder, and HIV-related health in HIV-positive men. J Trauma Dissociation. 2014;15:420–35. https://doi.org/10.1080/15299732.2013.873376.CrossRefPubMedPubMedCentral

80.

Wilson SM, Sikkema KJ, Ranby KW. Gender moderates the influence of psychosocial factors and drug use on HAART adherence in the context of HIV and childhood sexual abuse. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2014;26:959–67. https://doi.org/10.1080/09540121.2013.873765.CrossRef

81.

Borwein A, Salters KA, Palmer AK, Miller CL, Duncan KC, Chan K, et al. High rates of lifetime and recent violence observed among harder-to-reach women living with HIV. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2014;26:587–94. https://doi.org/10.1080/09540121.2013.844763.CrossRef

82.

Dale S, Cohen M, Weber K, Cruise R, Kelso G, Brody L. Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States. AIDS Patient Care STDs. 2014;28:136–43. https://doi.org/10.1089/apc.2013.0329.CrossRefPubMedPubMedCentral

83.

Mimiaga MJ, Noonan E, Donnell D, Safren SA, Koenen KC, Gortmaker S, et al. Childhood sexual abuse is highly associated with HIV risk-taking behavior and infection among MSM in the EXPLORE study. J Acquir Immune Defic Syndr. 2009;51:340–8. https://doi.org/10.1097/QAI.0b013e3181a24b38.CrossRefPubMedPubMedCentral

84.

Boroughs MS, Valentine SE, Ironson GH, Shipherd JC, Safren SA, Taylor SW, et al. Complexity of childhood sexual abuse: predictors of current post-traumatic stress disorder, mood disorders, substance use, and sexual risk behavior among adult men who have sex with men. Arch Sex Behav. 2015;44:1891–902. https://doi.org/10.1007/s10508-015-0546-9.CrossRefPubMedPubMedCentral

85.

Socias ME, Milloy MJ. Substance use and adherence to antiretroviral therapy: what is known and what is unknown. Curr Infect Dis Rep. 2018;20:36. https://doi.org/10.1007/s11908-018-0636-7.CrossRefPubMedPubMedCentral

86.

Lee WK, Milloy MJS, Nosova E, Walsh J, Kerr T. Predictors of antiretroviral adherence self-efficacy among people living with HIV/AIDS in a Canadian setting. J Acquir Immune Defic Syndr. 2019;80:103–9. https://doi.org/10.1097/QAI.0000000000001878.CrossRefPubMedPubMedCentral

87.

Cook PF, Schmiege SJ, Starr W, Carrington JM, Bradley-Springer L. Prospective state and trait predictors of daily medication adherence behavior in HIV. Nurs Res. 2017;66:275–85. https://doi.org/10.1097/NNR.0000000000000216.CrossRefPubMedPubMedCentral

88.

Shubber Z, Mills EJ, Nachega JB, Vreeman R, Freitas M, Bock P, et al. Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis. PLoS Med. 2016;13:e1002183. https://doi.org/10.1371/journal.pmed.1002183.CrossRefPubMedPubMedCentral

89.

Bulsara SM, Wainberg ML, Newton-John TRO. Predictors of adult retention in HIV care: a systematic review. AIDS Behav. 2018;22:752–64. https://doi.org/10.1007/s10461-016-1644-y.CrossRefPubMedPubMedCentral

90.

Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(Suppl 1):S19–25.CrossRef

91.

Voisin DR, Quinn K, Kim DH, Schneider J. A longitudinal analysis of antiretroviral adherence among young Black men who have sex with men. J Adolesc Health. 2017;60(4). https://doi.org/10.1016/j.jadohealth.2016.10.428.

92.

Kelly JA, St. Lawrence JS, Amirkhanian YA, DiFranceisco WJ, Anderson-Lamb M, Garcia LI, et al. Levels and predictors of HIV risk behavior among black men who have sex with men. AIDS Educ Prev. 2013;25(1):49–61. https://doi.org/10.1521/aeap.2013.25.1.49.CrossRefPubMedPubMedCentral

93.

Mimiaga MJ, Reisner SL, Fontaine YM, Bland SE, Driscoll MA, Isenberg D, et al. Walking the line: stimulant use during sex and HIV risk behavior among Black urban MSM. Drug Alcohol Depend. 2010;110:30–7. https://doi.org/10.1016/j.drugalcdep.2010.01.017.CrossRefPubMedPubMedCentral

94.

Mutchler MG, McDavitt B, Gordon KK. Becoming bold: alcohol use and sexual exploration among black and latino young men who have sex with men (YMSM). J Sex Res. 2014;51:696–710. https://doi.org/10.1080/00224499.2013.772086.CrossRefPubMed

95.

Sprague C, Simon SE. Understanding HIV care delays in the US South and the role of the social-level in HIV care engagement/retention: a qualitative study. Int J Equity Health. 2014;13(1):1.CrossRef

96.

Gwadz M, de Guzman R, Freeman R, et al. Exploring how substance use impedes engagement along the HIV care continuum: a qualitative study. Front Public Health. 2016;8(4):62.

97.

Fritz K, Morojele N, Kalichman S. Alcohol: the forgotten drug in HIV/AIDS. Lancet. 2010;376:398–400. https://doi.org/10.1016/S0140-6736(10)60884-7.CrossRefPubMedPubMedCentral

98.

Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52:180–202. https://doi.org/10.1097/QAI.0b013e3181b18b6e.CrossRefPubMedPubMedCentral

99.

Fatch R, Emenyonu NI, Muyindike W, Kekibiina A, Woolf-King S, Hahn JA. Alcohol interactive toxicity beliefs and ART non-adherence among HIV-infected current drinkers in Mbarara, Uganda. AIDS Behav. 2017;21:1812–24. https://doi.org/10.1007/s10461-016-1429-3.CrossRefPubMedPubMedCentral

100.

Kalichman SC, Horne R, Katner H, Hernandez D. Perceived sensitivity to medicines, alcohol interactive toxicity beliefs, and medication adherence among people living with HIV who drink alcohol. J Behav Med. 2019;42:392–400. https://doi.org/10.1007/s10865-018-9987-7.CrossRefPubMed

101.

Pellowski JA, Kalichman SC, Kalichman MO, Cherry C. Alcohol-antiretroviral therapy interactive toxicity beliefs and daily medication adherence and alcohol use among people living with HIV. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2016;28:963–70. https://doi.org/10.1080/09540121.2016.1154134.CrossRef

102.

Kuhns LM, Hotton AL, Garofalo R, Muldoon AL, Jaffe K, Bouris A, et al. An index of multiple psychosocial, syndemic conditions is associated with antiretroviral medication adherence among HIV-positive youth. AIDS Patient Care STDs. 2016;30(4):185–92.CrossRef

103.

• Gross IM, Hosek S, Richards MH, Fernandez MI. Predictors and profiles of antiretroviral therapy adherence among African American adolescents and young adult males living with HIV. AIDS Patient Care STDs. 2016;30(7):324–38 This study examines predictors of ART adherence among lack adolescents and young adult males living with HIV. Findings demonstrate that better adherence is associated with lower psychological distress and minimal alcohol use. CrossRef

104.

Horvath KJ, Lammert S, MacLehose RF, Danh T, Baker JV, Carrico AW. A pilot study of a Mobile app to support HIV antiretroviral therapy adherence among men who have sex with men who use stimulants. AIDS Behav. 2019;23:3184–98. https://doi.org/10.1007/s10461-019-02597-3.CrossRefPubMed

105.

Jin H, Ogunbajo A, Mimiaga MJ, Duncan DT, Boyer E, Chai P, et al. Over the influence: the HIV care continuum among methamphetamine-using men who have sex with men. Drug Alcohol Depend. 2018;192:125–8. https://doi.org/10.1016/j.drugalcdep.2018.07.038.CrossRefPubMedPubMedCentral

106.

Feldman MB, Thomas JA, Alexy ER, Irvine MK. Crystal methamphetamine use and HIV medical outcomes among HIV-infected men who have sex with men accessing support services in New York. Drug Alcohol Depend. 2015;147:266–71. https://doi.org/10.1016/j.drugalcdep.2014.09.780.CrossRefPubMed

107.

Low AJ, Mburu G, Welton NJ, May MT, Davies CF, French C, et al. Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and meta-analysis. Clin Infect Dis. 2016;63:1094–104. https://doi.org/10.1093/cid/ciw416.CrossRefPubMedPubMedCentral

108.

Shrestha R, Copenhaver MM. Viral suppression among HIV-infected methadone-maintained patients: the role of ongoing injection drug use and adherence to antiretroviral therapy (ART). Addict Behav. 2018;85:88–93. https://doi.org/10.1016/j.addbeh.2018.05.031.CrossRefPubMedPubMedCentral

109.

Bazzi AR, Drainoni ML, Biancarelli DL, Hartman JJ, Mimiaga MJ, Mayer KH, et al. Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions 11 Medical and Health Sciences 1117 Public Health and Health Se. BMC Public Health. 2019;19:31. https://doi.org/10.1186/s12889-018-6314-8.CrossRefPubMedPubMedCentral

110.

Gardner LI, Marks G, Strathdee SA, Loughlin AM, del Rio C, Kerndt P, et al. Faster entry into HIV care among HIV-infected drug users who had been in drug-use treatment programs. Drug Alcohol Depend. 2016;165:15–21. https://doi.org/10.1016/j.drugalcdep.2016.05.018.CrossRefPubMed

111.

Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158:725–30. https://doi.org/10.1176/appi.ajp.158.5.725.CrossRefPubMed

112.

Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus–infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–8. https://doi.org/10.1001/archpsyc.58.8.721.CrossRefPubMed

113.

Valente SM. Depression and HIV disease. J Assoc Nurses AIDS Care. 2003;14:41–51. https://doi.org/10.1177/1055329002250993.CrossRefPubMed

114.

Rabkin JG. HIV and depression: 2008 review and update. Curr HIV/AIDS Rep. 2008;5:163–71. https://doi.org/10.1007/s11904-008-0025-1.CrossRefPubMed

115.

Kavanagh DJ, Bower GH. Mood and self-efficacy: impact of joy and sadness on perceived capabilities. Cognit Ther Res. 1985;9:507–25. https://doi.org/10.1007/BF01173005.CrossRef

116.

White JM, Gordon JR, Mimiaga MJ. The role of substance use and mental health problems in medication adherence among HIV-infected MSM. LGBT Heal. 2014;1:319–22. https://doi.org/10.1089/lgbt.2014.0020.CrossRef

117.

Tucker A, Liht J, De Swardt G, et al. Homophobic stigma, depression, self-efficacy and unprotected anal intercourse for peri-urban township men who have sex with men in Cape Town, South Africa: a cross-sectional association model. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2014;26:882–9. https://doi.org/10.1080/09540121.2013.859652.CrossRef

118.

Williams JK, Wilton L, Magnus M, Wang L, Wang J, Dyer TP, et al. Relation of childhood sexual abuse, intimate partner violence, and depression to risk factors for HIV among black men who have sex with men in 6 US cities. Am J Public Health. 2015;105:2473–81. https://doi.org/10.2105/AJPH.2015.302878.CrossRefPubMedPubMedCentral

119.

Halkitis PN, Perez-Figueroa RE, Carreiro T, Kingdon MJ, Kupprat SA, Eddy J. Psychosocial burdens negatively impact HIV antiretroviral adherence in gay, bisexual, and other men who have sex with men aged 50 and older. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2014;26:1426–34. https://doi.org/10.1080/09540121.2014.921276.CrossRef

120.

Mitzel LD, Vanable PA, Brown JL, Bostwick RA, Sweeney SM, Carey MP. Depressive symptoms mediate the effect of HIV-related stigmatization on medication adherence among HIV-infected men who have sex with men. AIDS Behav. 2015;19:1454–9. https://doi.org/10.1007/s10461-015-1038-6.CrossRefPubMed

121.

Chen YH, Raymond HF. Associations between depressive syndromes and HIV risk behaviors among San Francisco men who have sex with men. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2017;29:1538–42. https://doi.org/10.1080/09540121.2017.1307925.CrossRef

122.

Uthman OA, Magidson JF, Safren SA, Nachega JB. Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV/AIDS Rep. 2014;11:291–307. https://doi.org/10.1007/s11904-014-0220-1.CrossRefPubMedPubMedCentral

123.

Singer M. Introduction to syndemics: a critical systems approach to public and community health.; Jossey-Bass, San Francisco, CA; 2009.

124.

Dyer TP, Shoptaw S, Guadamuz TE, Plankey M, Kao U, Ostrow D, et al. Application of syndemic theory to black men who have sex with men in the multicenter AIDS cohort study. J Urban Health. 2012;89(4):697–708.CrossRef

125.

Quinn K. Applying an intersectional framework to understand syndemic conditions among young Black gay, bisexual, and other men who have sex with men. Soc Sci Med. 2019:112779. https://doi.org/10.1016/j.socscimed.2019.112779.

126.

Singer M. A dose of drugs, a touch of violence, a case of AIDS: conceptualizing the SAVA syndemic. Free Inq Creat Sociol. 1996;24(2):99.

127.

Friedman MR, Stall R, Silvestre AJ, et al. Effects of syndemics on HIV viral load and medication adherence in the multicentre AIDS cohort study. AIDS. 2015;29(9):1087–96. https://doi.org/10.1097/QAD.0000000000000657.CrossRefPubMedPubMedCentral

128.

Stall R, Mills TC, Williamston J. Association of co-occurring psychosocial health problems and increased vulnerability to HIV/AIDS among urban men who have sex with men. Am J Public Health. 2003;93:939–42.CrossRef

129.

O’Leary A, Jemmott JB, Stevens R, Rutledge SE, Icard LD. Optimism and education buffer the effects of syndemic conditions on HIV status among African American men who have sex with men. AIDS Behav. 2014;18(11):2080–8.CrossRef

130.

Harkness A, Bainter SA, O’Cleirigh C, Mendez NA, Mayer KH, Safren SA. Longitudinal effects of syndemics on ART non-adherence among sexual minority men. AIDS Behav. 2018;22:2564–74. https://doi.org/10.1007/s10461-018-2180-8.CrossRefPubMedPubMedCentral

131.

Blashill AJ, Bedoya CA, Mayer KH, O’Cleirigh C, Pinkston MM, Remmert JE, et al. Psychosocial syndemics are additively associated with worse ART adherence in HIV-infected individuals. AIDS Behav. 2015;19(6):981–6.CrossRef

132.

Risher KA, Kapoor S, Daramola AM, Paz-Bailey G, Skarbinski J, Doyle K, et al. Challenges in the evaluation of interventions to improve engagement along the HIV care continuum in the United States: a systematic review. AIDS Behav. 2017;21:2101–23. https://doi.org/10.1007/s10461-017-1687-8.CrossRefPubMedPubMedCentral

133.

Muessig KE, LeGrand S, Horvath KJ, Bauermeister JA, Hightow-Weidman LB. Recent mobile health interventions to support medication adherence among HIV-positive MSM. Curr Opin HIV AIDS. 2017;12(5):432–41. https://doi.org/10.1097/COH.0000000000000401.CrossRefPubMedPubMedCentral

134.

Mbuagbaw L, Sivaramalingam B, Navarro T, Hobson N, Keepanasseril A, Wilczynski NJ, et al. Interventions for enhancing adherence to antiretroviral therapy (ART): a systematic review of high quality studies. AIDS Patient Care STDs. 2015;29:248–66. https://doi.org/10.1089/apc.2014.0308.CrossRefPubMedPubMedCentral

135.

Bogart LM, Wagner GJ, Green HD, et al. Medical mistrust among social network members may contribute to antiretroviral treatment nonadherence in African Americans living with HIV. Soc Sci Med. 2016;164:133–140.

136.

Oldenburg CE, Perez-Brumer AG, Hatzenbuehler ML, et al. State-level structural sexual stigma and HIV prevention in a national online sample of HIV-uninfected MSM in the United States. AIDS. 2015;29(7):837–45. https://doi.org/10.1097/QAD.0000000000000622.CrossRefPubMedPubMedCentral

137.

Van Tieu H, Koblin BA, Latkin C, et al. Neighborhood and network characteristics and the HIV care continuum among gay, bisexual, and other men who have sex with men. J Urban Health. 2018. https://doi.org/10.1007/s11524-018-0266-2.

138.

Reisner SL, Mimiaga MJ, Skeer M, Perkovich B, Johnson CV, Safren SA. A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. Top HIV Med. 2009;17(1):14–25.PubMedPubMedCentral

139.

Naar-King S, Outlaw AY, Sarr M, et al. Motivational Enhancement System for Adherence (MESA): pilot randomized trial of a brief computer-delivered prevention intervention for youth initiating antiretroviral treatment. J Pediatr Psychol. 2013;38(6):638–48. https://doi.org/10.1093/jpepsy/jss132.CrossRefPubMedPubMedCentral

140.

Garofalo R, Kuhns LM, Hotton A, Johnson A, Muldoon A, Rice D. A randomized controlled trial of personalized text message reminders to promote medication adherence among HIV-positive adolescents and young adults. AIDS Behav. 2016;20:1049–59. https://doi.org/10.1007/s10461-015-1192-x.CrossRefPubMedPubMedCentral

141.

Belzer ME, Naar-King S, Olson J, et al. The use of cell phone support for non-adherent HIV-infected youth and young adults: an initial randomized and controlled intervention trial. AIDS Behav. 2014;18:686–96. https://doi.org/10.1007/s10461-013-0661-3.CrossRefPubMedPubMedCentral

142.

Dowshen N, Kuhns LM, Johnson A, Holoyda BJ, Garofalo R. Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: a pilot study using personalized, interactive, daily text message reminders. J Med Internet Res. 2012;14:e51. https://doi.org/10.2196/jmir.2015.CrossRefPubMedPubMedCentral

143.

Kerrigan D, Grieb SM, Ellen J, Sibinga E. Exploring the dynamics of art adherence in the context of a mindfulness instruction intervention among youth living with HIV in Baltimore, Maryland. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2018;30:1400–5. https://doi.org/10.1080/09540121.2018.1492699.CrossRef

144.

Mimiaga MJ, Kuhns LM, Biello KB, Olson J, Hoehnle S, Santostefano CM, et al. Positive STEPS - a randomized controlled efficacy trial of an adaptive intervention for strengthening adherence to antiretroviral HIV treatment among youth: study protocol. BMC Public Health. 2018;18:867. https://doi.org/10.1186/s12889-018-5815-9.CrossRefPubMedPubMedCentral

145.

Sayegh CS, MacDonell KK, Clark LF, et al. The impact of cell phone support on psychosocial outcomes for youth living with HIV nonadherent to antiretroviral therapy. AIDS Behav. 2018;22:3357–62. https://doi.org/10.1007/s10461-018-2192-4.CrossRefPubMedPubMedCentral

146.

Shaw S, Amico KR. Antiretroviral therapy adherence enhancing interventions for adolescents and young adults 13-24 years of age: a review of the evidence base. J Acquir Immune Defic Syndr. 2016;72:387–99. https://doi.org/10.1097/QAI.0000000000000977.CrossRefPubMedPubMedCentral

147.

• Hosek SG, Harper GW, Lemos D, et al. Project ACCEPT: evaluation of a group-based intervention to improve engagement in Care for Youth Newly Diagnosed with HIV. AIDS Behav. 2018. https://doi.org/10.1007/s10461-018-2034-4This study presents the findings of a promising pilot intervention to improve engagement in care for youth living with HIV. Findings demonstrate the intervention was positively associated with ART adherence and declining viral load over time.

148.

Thurston IB, Bogart LM, Wachman M, Closson EF, Skeer MR, Mimiaga MJ. Adaptation of an HIV medication adherence intervention for adolescents and young adults. Cogn Behav Pract. 2014;21(2):191–205.CrossRef

149.

Holloway IW, Tan D, Dunlap SL, Palmer L, Beougher S, Cederbaum JA. Network support, technology use, depression, and ART adherence among HIV-positive MSM of color. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2017;29:1153–61. https://doi.org/10.1080/09540121.2017.1325435.CrossRef

150.

LeGrand S, Muessig KE, McNulty T, Soni K, Knudtson K, Lemann A, et al. Epic allies: development of a gaming app to improve antiretroviral therapy adherence among young HIV-positive men who have sex with men. JMIR Serious Games. 2016;4. https://doi.org/10.2196/games.5687.

151.

Horvath KJ, Michael Oakes J, Simon Rosser BR, Danilenko G, Vezina H, Rivet Amico K, et al. Feasibility, acceptability and preliminary efficacy of an online peer-to-peer social support ART adherence intervention. AIDS Behav. 2013;17:2031–44. https://doi.org/10.1007/s10461-013-0469-1.CrossRefPubMedPubMedCentral

152.

Horvath KJ, Amico KR, Erickson D, Ecklund AM, Martinka A, DeWitt J, et al. Thrive with me: protocol for a randomized controlled trial to test a peer support intervention to improve antiretroviral therapy adherence among men who have sex with men. JMIR Res Protoc. 2018;7:e10182. https://doi.org/10.2196/10182.CrossRefPubMedPubMedCentral

153.

Horvath KJ, Alemu D, Danh T, Baker JV, Carrico AW. Creating effective mobile phone apps to optimize antiretroviral therapy adherence: perspectives from stimulant-using HIV-positive men who have sex with men. JMIR mHealth uHealth. 2016;4:e48. https://doi.org/10.2196/mhealth.5287.CrossRefPubMedPubMedCentral

154.

Locher C, Messerli M, Gaab J, Gerger H. Long-term effects of psychological interventions to improve adherence to antiretroviral treatment in HIV-infected persons: a systematic review and meta-analysis. AIDS Patient Care STDs. 2019;33:131–44. https://doi.org/10.1089/apc.2018.0164.CrossRefPubMed

155.

Amico KR. Evidence for technology interventions to promote ART adherence in adult populations: a review of the literature 2012–2015. Curr HIV/AIDS Rep. 2015;12(4):441–50. https://doi.org/10.1007/s11904-015-0286-4.CrossRefPubMedPubMedCentral

156.

Haberer JE, Sabin L, Amico KR, Orrell C, Galárraga O, Tsai AC, et al. Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations. J Int AIDS Soc. 2017;20(1):21371. https://doi.org/10.7448/IAS.20.1.21371.CrossRefPubMedPubMedCentral

157.

Macdonell KE, Naar-King S, Murphy DA, Parsons JT, Harper GW. Predictors of medication adherence in high risk youth of color living with HIV. J Pediatr Psychol. 2010;35(6):593–601. https://doi.org/10.1093/jpepsy/jsp080.CrossRefPubMed

Titel: ART Adherence Among Men Who Have Sex with Men Living with HIV: Key Challenges and Opportunities
verfasst von: Katherine G. Quinn
Dexter R. Voisin
Publikationsdatum: 18.06.2020
Verlag: Springer US
Erschienen in: Current HIV/AIDS Reports / Ausgabe 4/2020
Print ISSN: 1548-3568
Elektronische ISSN: 1548-3576
DOI: https://doi.org/10.1007/s11904-020-00510-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

ART Adherence Among Men Who Have Sex with Men Living with HIV: Key Challenges and Opportunities

Abstract

Purpose of Review

Recent Findings

Summary

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Universal HIV Testing and Treatment (UTT) Integrated with Chronic Disease Screening and Treatment: the SEARCH study

Sex Differences in the Treatment of HIV

The Evidence for HIV Self-Testing to Increase HIV Testing Rates and the Implementation Challenges that Remain

From Berlin to London: HIV-1 Reservoir Reduction Following Stem Cell Transplantation

A Systematic Review of Technology-Assisted HIV Testing Interventions

A Systematic Review of Recent Methodological Approaches for Using Ecological Momentary Assessment to Examine Outcomes in U.S. Based HIV Research

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin